Veterinary PCR panels market seen reaching $1.77 billion by 2030

The veterinary rapid syndromic PCR panels market is projected to grow from $1.22 billion in 2025 to $1.77 billion by 2030, driven by rising animal infectious diseases, pet ownership and demand for faster diagnostics. North America led in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Veterinary rapid syndromic PCR panels are becoming a key diagnostic tool as animal health providers look for faster detection of infectious diseases. - The market’s growth reflects broader pressure on veterinarians and livestock operators to identify multiple pathogens quickly and support earlier treatment decisions. - Rising antimicrobial resistance is adding urgency to more precise testing.

What happened: - The veterinary rapid syndromic polymerase chain reaction panels market is projected to rise from $1.22 billion in 2025 to $1.31 billion in 2026. - The market is forecast to reach $1.77 billion by 2030. - The report models a 7.5% CAGR from 2025 to 2026 and a 7.8% CAGR through 2030. - The Business Research Company published the forecast in its 2026 market report on veterinary rapid syndromic PCR panels. - The report includes a free sample and a full version available online: Download the sample report and View the full report.

The details: - Growth is tied to more frequent zoonotic disease outbreaks, higher investment in intensive livestock farming, higher companion animal healthcare spending and limits of traditional culture-based diagnostics. - The report also cites growing awareness of antimicrobial resistance as a market driver. - Veterinary rapid syndromic PCR panels detect multiple infectious agents from a single sample. - The technology supports faster diagnosis and more targeted disease management in animals. - In November 2023, the Colorado Department of Agriculture reported canine infectious respiratory disease cases doubled versus typical outbreak levels. - Similar surges were documented across at least 10 U.S. states between 2022 and 2023. - The American Veterinary Medical Association reported in December 2024 that the U.S. dog population increased from 80.1 million in 2023 to 89.7 million in 2024. - That was an increase of about 9.6 million dogs in one year.

Between the lines: - The forecast suggests veterinary diagnostics are shifting toward multiplex, rapid testing as animal populations grow and infectious disease monitoring becomes more important. - Companion animal spending and livestock biosecurity are pulling demand in the same direction. - North America’s lead in 2025 points to an established market for advanced veterinary tools, while faster Asia-Pacific growth signals more room for adoption as livestock and pet ownership expand.

What's next: - The market is expected to keep expanding through 2030 as veterinary clinics, animal health companies and livestock operators seek faster multi-pathogen testing. - The report says Asia-Pacific will be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspot infographics and updated trend analysis.

The bottom line: - Veterinary rapid syndromic PCR panels are moving from niche diagnostics toward mainstream animal health infrastructure, with demand rising fastest where disease pressure and pet ownership are both increasing.